Correction to: Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial

A correction to this paper has been published: https://doi.org/10.1007/s00277-021-04545-5
Source: Annals of Hematology - Category: Hematology Source Type: research